FGOVX | RGVEX | FGOVX / RGVEX | |
Total Expense Ratio | 0.44 | 0.59 | 75% |
Annual Report Gross Expense Ratio | 0.44 | 0.63 | 70% |
Fund Existence | 46 years | 23 years | - |
Gain YTD | 3.238 | 4.000 | 81% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.75B | 23B | 8% |
Annual Yield % from dividends | 3.78 | 4.12 | 92% |
Returns for 1 year | 4.21 | 5.20 | 81% |
Returns for 3 years | 4.06 | 3.51 | 116% |
Returns for 5 years | -9.38 | -8.23 | 114% |
Returns for 10 years | 7.00 | 5.91 | 118% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FBT | 168.85 | 1.74 | +1.04% |
First Trust NYSE Arca Biotech ETF | |||
EWV | 33.83 | 0.27 | +0.80% |
ProShares UltraShort MSCI Japan | |||
MHNC | 16.88 | 0.13 | +0.78% |
MAIDEN HOLDINGS NORTH AMERICA Ltd | |||
MGOV | 20.05 | -0.01 | -0.03% |
First Trust Intermediate Gvt Opps ETF | |||
EOD | 5.46 | -0.03 | -0.55% |
Allspring Global Dividend Opportunity Fund |